Ascendis Pharma A (ASND) FCF Margin (QoQ) (2014 - 2026)
Ascendis Pharma A (ASND) FCF Margin (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,239.00 |
| Dec 31, 2025 | -2,653.00 |
| Sep 30, 2025 | 565.00 |
| Jun 30, 2025 | 953.00 |
| Mar 31, 2025 | 1,395.00 |
| Dec 31, 2024 | 6,813.00 |
| Sep 30, 2024 | 7,311.00 |
| Jun 30, 2024 | -6,364.00 |
| Mar 31, 2024 | -9,167.00 |
| Dec 31, 2023 | 24,356.00 |
| Sep 30, 2023 | 6,455.00 |
| Jun 30, 2023 | 11,238.00 |
| Mar 31, 2023 | 16,330.00 |
| Dec 31, 2022 | 2,786.00 |
| Sep 30, 2022 | 133,318.00 |
| Jun 30, 2022 | -9,933.00 |
| Mar 31, 2022 | -166,458.00 |
| Dec 31, 2021 | 755,157.00 |
| Sep 30, 2021 | 317,508.00 |
| Jun 30, 2021 | -52,028.00 |